Episode: Cancer Mythbusters Episode #6 – Is Palliative Care Only for End-of-Life Patients?


Cancer Podcasts from Dana-Farber Logo
Subscribe
Cancer Mythbusters Episode #6 – Is Palliative Care Only for End-of-Life Patients?

Palliative care is an often misunderstood specialty, focused on providing support and pain management strategies to cancer patients throughout all stages of their illness. This approach, which can be blended into curative cancer therapy, focuses on care for the whole person: mind, body, and spirit. Read More: Oncology and Palliative […]

The post Cancer Mythbusters Episode #6 – Is Palliative Care Only for End-of-Life Patients? appeared first on Dana-Farber Cancer Institute.



Cancer Podcasts from Dana-Farber
Users who viewed this episode also viewed...

Cancer Podcasts from Dana-Farber > Cancer Conversations Podcast – Episode #10: Melanoma — What’s the Latest?

Although less common than other types of skin cancer, melanoma is a dangerous disease that can spread rapidly if it is not caught early. In addition to regular self exams, it is crucial to protect yourself from the damaging effects of the sun -- regardless of your age, skin color, or the time of year...

Cancer Podcasts from Dana-Farber > Voices Podcast – Season 2 Episode #3: Then and Now with Male Breast Cancer Survivor Mike Johnston

When Mike Johnston felt a lump in his chest in 2009, he assumed it was a side effect of a high blood pressure medication. But after a routine doctor’s visit, followed by a mammogram and ultrasound, Johnston’s diagnosis was confirmed: He had male breast cancer. Only 2,000 men in the […] The post Voices Podcast – Season 2 Episode #3: Then and Now with Male Breast Cancer Survivor Mike Johnston appeared first on Dana-Farber Cancer Institute...

Cancer Podcasts from Dana-Farber > Cancer Conversations Podcast – Episode #9: Precision Medicine and Lung Cancer

Although lung cancer is only the second most common cancer in the United States, it is by far the deadliest cancer in both men and women. But thanks to advancements in precision medicine, treatments for lung cancer are improving, and many patients are benefiting from these new, targeted therapies. “When we find we have drugs targeted for a specific genetic mutation driving the cancer, the chance of having someone live longer and feel better is much higher,” says David Jackman, MD, a medical oncologist with Dana-Farber’s Lowe Center for Thoracic Oncology and the institute’s Medical Director for Clinical Pathways...
Comments (0)

Login or Sign up to leave a comment.

Log in
Sign up

Be the first to comment.